These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings. Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562 [TBL] [Abstract][Full Text] [Related]
5. Successful engraftment following HLA-mismatched cord blood transplantation for patients with anti-HLA Abs. Kataoka K; Yamamoto G; Nannya Y; Yoshimi A; Okada S; Asai T; Kumano K; Hangaishi A; Takahashi T; Chiba S; Kurokawa M Bone Marrow Transplant; 2008 Jul; 42(2):129-30. PubMed ID: 18362901 [No Abstract] [Full Text] [Related]
6. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M Clin Transpl; 2007; ():219-26. PubMed ID: 18642453 [TBL] [Abstract][Full Text] [Related]
7. Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation. Fouillard L; Chapel A; Bories D; Bouchet S; Costa JM; Rouard H; Hervé P; Gourmelon P; Thierry D; Lopez M; Gorin NC Leukemia; 2007 Mar; 21(3):568-70. PubMed ID: 17252011 [No Abstract] [Full Text] [Related]
8. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687 [TBL] [Abstract][Full Text] [Related]
9. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation. Bingaman AW; Murphey CL; Palma-Vargas J; Wright F Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435 [TBL] [Abstract][Full Text] [Related]
10. Successful deceased-donor kidney transplantation in crossmatch-positive patients with peritransplant plasma exchange and Rituximab. Beimler JH; Morath C; Schmidt J; Ovens J; Opelz G; Rahmel A; Zeier M; Süsal C Transplantation; 2009 Mar; 87(5):668-71. PubMed ID: 19295310 [TBL] [Abstract][Full Text] [Related]
11. [Donor peripheral stem cells infusion for the treatment of failure of platelet recovery after allogeneic hematopoietic stem cell transplantation]. Chen Y; Xu LP; Liu DH; Chen YH; Han W; Shi HX; Zhang XH; Wang JZ; Chen H; Liu KY; Huang XJ; Lu DP Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):964-6. PubMed ID: 17650420 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantation. Or R; Hadar E; Bitan M; Resnick IB; Aker M; Ackerstein A; Samuel S; Tsirigotis P; Gesundheit B; Slavin S; Shapira MY Biol Blood Marrow Transplant; 2006 Dec; 12(12):1295-301. PubMed ID: 17162211 [TBL] [Abstract][Full Text] [Related]
13. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up. Lachmann N; Terasaki PI; Schönemann C Clin Transpl; 2006; ():171-99. PubMed ID: 18365377 [TBL] [Abstract][Full Text] [Related]
14. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
15. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility. Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092 [TBL] [Abstract][Full Text] [Related]
16. Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation. Schumm M; Feuchtinger T; Pfeiffer M; Hoelle W; Bethge W; Ebinger M; Kuci S; Handgretinger R; Lang P Bone Marrow Transplant; 2007 Jun; 39(12):767-73. PubMed ID: 17438586 [TBL] [Abstract][Full Text] [Related]